Document is current

Any future updates will be listed below

Author Correction: Combination of PARP and KRASG12D inhibitors enhances therapeutic efficacy by exploiting vulnerabilities in PDAC

Crossref DOI link: https://doi.org/10.1038/s41467-026-72371-2

Published Online: 2026-04-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark